Targeting Pulmonary Hypertension: Elucidating Sophocarpine's Protective Role via Preclinical Models. | Synapse
February 27, 2026
Targeting Pulmonary Hypertension: Elucidating Sophocarpine's Protective Role via Preclinical Models.
Key Points
To investigate the protective role of sophocarpine in pulmonary hypertension.
Used preclinical models to assess the effects of sophocarpine
Evaluated pulmonary hypertension indicators
Conducted statistical analyses of therapeutic effects
Sophocarpine showed a significant protective effect in the pulmonary hypertension model
Indications of reduced symptoms and improved outcomes were observed
Potential for sophocarpine as a therapeutic agent for pulmonary hypertension was established
Abstract
Our study provides clear evidence that SOP has a significant protective effect in the PH model and is expected to be a promising therapeutic agent for PH.